Search results with tag "Dcpar"
DCPAR for Lubion 25 mg Powder for Solution for …
www.mhra.gov.ukPAR Lubion 25 mg Powder for solution for Injection and Lubion 25 mg Solution for Injection UK/H/4170/001-02/DC 2 Lubion 25 mg Powder for Solution for Injection
DCPAR Fenofibrate 160mg Film-coated Tablets PL …
www.mhra.gov.ukPAR Fenofibrate 160mg Film-coated Tablets UK/H/1566/01/DC 2 LAY SUMMARY On the 21st January 2010 the MHRA granted Teva UK Limited a Marketing Authorisation (licence) for the medicinal product Fenofibrate 160mg Film-coated Tablets.
DCPAR for Elvanse 30mg 50 mg and 70 mg hard Capsules …
www.mhra.gov.ukPAR Elvanse 30 mg, 50 mg and 70 mg capsules, hard UK/H/3326/001-003/DC 2 LAY SUMMARY This is a summary of the Public Assessment Report (PAR) for Elvanse 30 mg, 50 mg and
DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 …
www.mhra.gov.ukPAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure
pCard Overview & Updates - Hawaii Procurement
spo.hawaii.gov2/13/2014 02/2014 1 state procurement office 2014 procurement training for state & county purchasing personnel pcard overview & updates the gotowebinar attendee view
Similar queries
DCPAR for Lubion 25 mg Powder for Solution for, Lubion 25 mg Powder for Solution for Injection, Lubion 25 mg Solution for Injection, DCPAR Fenofibrate 160mg Film-coated Tablets PL, Fenofibrate 160mg Film-coated Tablets, DCPAR for Elvanse 30mg 50 mg, Elvanse 30 mg, 50 mg, For Elvanse 30 mg, DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1, Ampicillin, 5 g and 2 g, Solution, Pcard overview & updates